UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039329
Receipt number R000044856
Scientific Title Examination of effectiveness of Paravertebral Block multiple injection for respiratory surgery Comparative study of blinding observers by stratified randomization
Date of disclosure of the study information 2020/02/04
Last modified on 2021/08/01 09:05:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of effectiveness of Paravertebral Block multiple injection for respiratory surgery
Comparative study of blinding observers by stratified randomization

Acronym

Examination of effectiveness of Paravertebral Block multiple injection for respiratory surgery
Comparative study of blinding observers by stratified randomization

Scientific Title

Examination of effectiveness of Paravertebral Block multiple injection for respiratory surgery
Comparative study of blinding observers by stratified randomization

Scientific Title:Acronym

Examination of effectiveness of Paravertebral Block multiple injection for respiratory surgery
Comparative study of blinding observers by stratified randomization

Region

Japan


Condition

Condition

Respiratory Surgery

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Good postoperative analgesia in respiratory surgery is important for recovery of respiratory function and early ambulation. Until now, epidural anesthesia was considered to be a gold standard, but now paravertebral blocks are performed under ultrasound guidance, and the analgesic effect equivalent to epidural anesthesia has been obtained.
When performing a paravertebral block, the drug is often administered in a single shot between the target ribs, but it is reported that the effect was obtained over a wider area by puncturing multiple times between adjacent ribs and administering the drug Are scattered.
However, there are few reports that widespread use of drugs is effective for postoperative analgesia.
In this study, we considered that performing paravertebral block multiple injection in respiratory surgery is likely to provide better analgesia than performing a single shot, and conducted a randomized controlled trial 48 hours after surgery. The effectiveness of the NRS until the outcome

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

NRS

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

single injection of TPVB

Interventions/Control_2

multiple injection of TPVB

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients performing respiratory surgery in the operating room of Juntendo University Shizuoka Hospital

Key exclusion criteria

Patients with simultaneous bilateral surgery
Patients who determine that epidural anesthesia is appropriate for postoperative analgesia
Patients with lesions that are not suitable for puncturing the skin at the puncture site
Patients with a history of allergy to local anesthetics
Patients whose procedure is considered to be dangerous
Patients with renal dysfunction
Patients with a history of asthma attack
In addition, patients who the investigator judged to be inappropriate as subjects

Target sample size

92


Research contact person

Name of lead principal investigator

1st name Shuhei
Middle name
Last name Yonemoto

Organization

Juntendo University Shizuoka Hospital

Division name

anesthesiology

Zip code

4102295

Address

1129 Nagaoka, Izunokuni, Shizuoka Prefecture

TEL

0559483111

Email

s-yonemoto@juntendo.ac.jp


Public contact

Name of contact person

1st name Shuhei
Middle name
Last name Yonemoto

Organization

Juntendo University Shizuoka Hospital

Division name

anesthesiology

Zip code

4102295

Address

1129 Nagaoka, Izunokuni, Shizuoka Prefecture

TEL

0559483111

Homepage URL


Email

s-yonemoto@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University Shizuoka Hospital

Institute

Department

Personal name



Funding Source

Organization

Juntendo University Shizuoka Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University Shizuoka Hospital

Address

1129 Nagaoka, Izunokuni, Shizuoka Prefecture

Tel

0559483111

Email

s-yonemoto@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 01 Month 21 Day

Date of IRB

2020 Year 02 Month 10 Day

Anticipated trial start date

2020 Year 02 Month 11 Day

Last follow-up date

2022 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 01 Month 30 Day

Last modified on

2021 Year 08 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044856


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name